新型冠状病毒奥密克戎变异株感染重症高危人群症状及中医证候学特征探析

方辉; 张宁; 王玉光; 郭亚丽; 祝勇; 刘建

doi:10.3969/j.issn.2095-6606.2023.04.006

您当前的位置：

首页 >

文章列表页 >

新型冠状病毒奥密克戎变异株感染重症高危人群症状及中医证候学特征探析

COVID-19专题 | 更新时间：2023-08-07

- 新型冠状病毒奥密克戎变异株感染重症高危人群症状及中医证候学特征探析
- Analysis of symptoms and TCM syndrome characteristics of the Omicron variant of COVID-19 in severe high-risk population
- 现代中医临床 2023年30卷第4期页码：28-33
- 作者机构：
  
  1.北京中医药大学　北京　100029
  2.首都医科大学附属北京中医医院
  3.北京中医医院内蒙古医院
- 作者简介：
  
  方辉，女，在读博士生
  # 刘建，男，硕士，主治医师，E-mail：liujian5065@163.com
- 基金信息：
  
  高层次公共卫生技术人才培养建设项目(学科带头人－01－16)
- DOI：10.3969/j.issn.2095-6606.2023.04.006
  中图分类号： R259
- 纸质出版日期：2023-07-30，
  
  收稿日期：2023-04-18，
- 稿件说明：
移动端阅览
方辉, 张宁, 王玉光, 等. 新型冠状病毒奥密克戎变异株感染重症高危人群症状及中医证候学特征探析[J]. 现代中医临床, 2023,30(4):28-33.

FANG Hui, ZHANG Ning, WANG Yuguang, et al. Analysis of symptoms and TCM syndrome characteristics of the Omicron variant of COVID-19 in severe high-risk population[J]. Modern Chinese Clinical Medicine, 2023,30(4):28-33.
方辉, 张宁, 王玉光, 等. 新型冠状病毒奥密克戎变异株感染重症高危人群症状及中医证候学特征探析[J]. 现代中医临床, 2023,30(4):28-33. DOI： 10.3969/j.issn.2095-6606.2023.04.006.

FANG Hui, ZHANG Ning, WANG Yuguang, et al. Analysis of symptoms and TCM syndrome characteristics of the Omicron variant of COVID-19 in severe high-risk population[J]. Modern Chinese Clinical Medicine, 2023,30(4):28-33. DOI： 10.3969/j.issn.2095-6606.2023.04.006.

摘要

目的

分析北京地区新型冠状病毒(简称“新冠”)奥密克戎变异株感染重症高危人群病例的症状及中医证候学特征。

方法

采用横断面调查研究，选取217例于首都医科大学附属北京中医医院、北京中医医院顺义医院收治的新冠奥密克戎变异株感染重症患者，收集患者一般资料，包括性别、年龄、吸烟史、症状、体征、合并症、既往用药史等。采集患者中医四诊信息。

结果

217例新冠奥密克戎变异株感染高危患者中，合并心脑血管病者最多，共191例。呼吸系统表现中，咳嗽、咳痰、憋气和心胸症状出现频次较多。其他中医优势症状方面，周身感觉异常出现频次最多，占99.08%，消化系统症状多见腹胀、食欲减退，神志方面症状可见睡眠异常以及精神异常。二便方面以小便不利、便溏为主。舌色以淡红舌(33.18%)、淡白舌(30.41%)为主，淡暗舌(11.52%)少见；舌体可见胖大(20.28%)。舌苔主要有薄苔(31.80%)、腻苔(29.95%)、黄苔(28.57%)。脉象以滑脉(38.71%)、细脉(27.19%)、弱脉(25.81%)以及沉脉(24.42%)最为常见。中医证候方面，以肺脾气虚证最多(34.10%)，其次是气阴两虚证(24.42%)和邪热郁肺证(17.51%)。

结论

新冠奥密克戎变异株感染重症高危患者，病因为感受疫疠之气，病因病机的关键在于虚，基本病理特点主要表现为痰凝、血瘀与外邪相杂，肺脾气虚证和气阴两虚证为主要中医证候。

Abstract

Objective

To analyze the symptoms and TCM syndrome characteristics of patients infected with the Omicron variant of COVID-19 in Beijing

in order to provide a theoretical and scientific basis for better understanding and treatment of the disease.

Methods

A cross-sectional study was conducted

in which a total of 217 severe cases of COVID-19 infection with Omicron variant strain in Beijing Hospital of Traditional Chinese Medicine affiliated to Capital Medical University and Shunyi Hospital of Beijing Hospital of Traditional Chinese Medicine from December 2022 to January 2023 were reviewed. General patient information

including gender

age

smoking history

symptoms

signs

comorbidities

and past medication history

and also manifestations in terms of the four TCM methods of diagnosis was collected.

Results

Among the 217 patients at high risk for COVID-19 infections

those with combined cardiovascular and cerebrovascular diseases were the most frequent

with 191 cases. Among the respiratory system manifestations

cough

phlegm

chest tightness and cardiothoracic symptoms appeared more frequently. In terms of other TCM dominant symptoms

peripheral sensory abnormalities appeared most frequently

accounting for 99.08%

while digestive system symptoms were mostly seen in abdominal distension and loss of appetite

and mental symptoms were seen in abnormal sleep and mental abnormalities. In terms of urination and defecation

the main symptoms were dysuria and loose stools. The tongue color was mainly light red (33.18%) and light white (30.41%)

and light dark tongue (11.52%) was rare; the tongue body was fat (20.28%). Tongue coating was mainly thin (31.80%)

greasy (29.95%)

and yellow (28.57%). Slippery pulse (38.71%)

thready pulse (27.19%)

weak pulse (25.81%)

and deep pulse (24.42%) were the most common. In terms of TCM symptoms

lung-qi deficiency was the most frequent (34.10%)

followed by qi-yin deficiency (24.42%) and evil-heat stagnation in the lung (17.51%).

Conclusion

The TCM syndrome of the severe cases infected with the Omicron variant of COVID-19 were mainly qi deficiency in the lung and spleen and deficiency of both qi and yin.

关键词

新型冠状病毒感染重症高危人群奥密克戎变异株中医证候特征

Keywords

COVID-19 infectionsevere illnesshigh-risk groupsomicron variant strainscharacteristics of TCM syndromes

references

李懿，徐英春. 新冠疫情的新挑战：Omicron变异株特征及科学防疫新阶段[J]. 协和医学杂志，2023,14(1):9-17.

中华人民共和国国家卫生健康委员会办公厅，中华人民共和国国家中医药管理局综合司. 新型冠状病毒感染诊疗方案(试行第十版)[J].中国医药，2023,18(2):161-166.

国家市场监督管理总局，国家标准化管理委员会.中医临床诊疗术语第2部分：证候：GB/T16751.1－2021[S].北京：中国标准出版社，2021.

深圳市第三人民医院，国家感染性疾病临床医学研究中心，深圳市感染性疾病质量控制中心.深圳市成人新型冠状病毒奥密克戎变异株感染重症临床救治专家共识[J].新发传染病电子杂志，2023,8(1):93-101.

REPORT G. Global strategy for prevention, diagnosis and management of COPD[EB/OL] . [2023-04-14].https://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdfhttps://goldcopd.org/wp-content/uploads/2020/11/GOLD-REPORT-2021-v1.1-25Nov20_WMV.pdf.

GUAN W, LIANG W, ZHAO Y, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis [J/OL]. Eur Respir J,2020,55(5):2000547[2023-04-14].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7098485/.

ZHANG X, ZHANG W, CHEN S. Shanghai’s life-saving efforts against the current omicron wave of the COVID-19 pandemic [J]. Lancet (London, England), 2022, 399(10340):2011-2012.

SHIN J, GAO Y, MOORE J, et al. Innate immune response and outcome of clostridium difficile infection are dependent on fecal bacterial composition in the aged host [J]. J Infect Dis，2018,217(2):188-197.

SALMINEN A. Activation of immunosuppressive network in the aging process [J/OL]. Ageing Res Rev,2020,57:100998[2023-04-14].https://linkinghub.elsevier.com/retrieve/pii/S1568-1637(19)30319-8https://linkinghub.elsevier.com/retrieve/pii/S1568-1637(19)30319-8.

YOUSSEF J, NOVOSAD S, WINTHROP K. Infection risk and safety of corticosteroid use [J]. Rheum Dis Clin North Am，2016,42(1)157-176.

杨天涵，张晓燕，徐建青. 新型冠状病毒疫苗：现状与展望 [J].中国感染控制杂志，2021,20(7):673-680.

KADONO T. Immune-related adverse events by immune checkpoint inhibitors[J]. Jpn J Clin Immunol，2017,40(2):83-89.

MENON R, OTTO E, SEALFON R, et al. SARS-CoV－2 receptor networks in diabetic and COVID-19－associated kidney disease [J].Kidney Int，2020,98(6):1502-1518.

LUMPUY-CASTILLO J，LORENZO-ALMORÓS A, PELLO-LÁZARO A, et al. Cardiovascular damage in COVID-19: therapeutic approaches targeting the renin-angiotensin-aldosterone system [J/OL].Int J Mol Sci,2020,21(18):6471[2023-04-14].https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555368/https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555368/.

WANG F, MA Y, XU S, et al. Prevalence and risk of COVID-19 in patients with rheumatic diseases: a systematic review and meta-analysis [J].Clin Rheumatol，2022,41(7):2213-2223.

CURTIS J, JOHNSON S, ANTHONY D, et al. American college of rheumatology guidance for COVID-19 vaccination in patients with rheumatic and musculoskeletal diseases：Version 1 [J]. Arthritis Rheumatol，2021,73(7):1093-1107.

中华人民共和国国家卫生健康委员会. 新型冠状病毒感染重症病例诊疗方案(试行第四版) [J]. 全科医学临床与教育，2023,21(2):101-103.

叶桂. 温热论[M].北京：人民卫生出版社，2007: 15.

胡晓芬，曾圆圆，徐亚文，等. 姜良铎论内伤基础上的外感咳喘诊治 [J]. 环球中医药， 2021, 14(4):655-657.

何梦瑶. 医碥[M].北京：中国医药科技出版社，2014: 7.

浏览量

130

下载量

CSCD

文章被引用时，请邮件提醒。

提交

工具集

关联资源

暂无数据